CHARACTERIZATION OF ADSORPTION BEHAVIOR BY SOLID DOSAGE FORM EXCIPIENTS IN FORMULATION DEVELOPMENT

被引:6
|
作者
SENDEROFF, RI
MAHJOUR, M
RADEBAUGH, GW
机构
[1] Parke Davis Pharmaceutical Research Division, Warner-Lambert Co., Morris Plains
关键词
ABSORPTION; SOLID DOSAGE FORM EXCIPIENT; MICROCRYSTALLINE CELLULOSE; CROSCARMELLOSE SODIUM; SODIUM STARCH GLYCOLATE; IONIC STRENGTH EFFECT; PH EFFECT; ADSORPTION;
D O I
10.1016/0378-5173(82)90009-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The adsorption of drugs onto solid dosage form excipients may influence dissolution characteristics, analytical testing and bioavailability. CI-977 ([5R-(5-alpha,7-alpha,8-beta)]-N-methyl-N-[7-(pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-4-benzofuranacetamide monohydrochloride), a kappa-opioid agonist analgesic compound, was found to adsorb onto microcrystalline cellulose, croscarmellose and sodium starch glycolate. The extent of adsorption was affected by pH, ionic strength and ionic species. The adsorptive capacity and relative affinity for CI-977 adsorption to microcrystalline cellulose was characterized under various experimental conditions using Langmuir isotherms. The results show that electrolytes inhibit adsorption by reducing both the affinity of the adsorbent for the adsorbate and the adsorptive capacity of the adsorbent. Divalent cations reduced the adsorption to a greater extent than monovalent cations. The effects of pH and electrolytes suggest that the predominant mechanism of CI-977 adsorption to microcrystalline cellulose is electrostatic attractive forces.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 50 条
  • [1] DEVELOPMENT OF A SOLID DOSAGE FORM WITH ADSORPTION ACTIVITY
    Chirkova, M., V
    Gulyaev, D. K.
    Chugunova, M. P.
    Belonogova, V. D.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2020, 8 (04): : 233 - 241
  • [2] Effect of formulation excipients and the manufacturing process for solid dosage form on the initial dissolution of theophylline
    Viana, M
    Caramigeas, E
    Vachon, MG
    N'Dri, B
    Chulia, D
    STP PHARMA SCIENCES, 2000, 10 (05): : 363 - 371
  • [3] Formulation and characterization of glipizide solid dosage form with enhanced solubility
    Alotaibi, Badriyah Shadid
    Khan, Muhammad Ahsan
    Ullah, Kaleem
    Yasin, Haya
    Mannan, Abdul
    Khan, Shujaat Ali
    Murtaza, Ghulam
    PLOS ONE, 2024, 19 (02):
  • [4] Amlodipine besylate-excipients interaction in solid dosage form
    Abdoh, A
    Al-Omari, MM
    Badwan, AA
    Jaber, AMY
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2004, 9 (01) : 15 - 24
  • [5] Solid-state compatibility screening of excipients suitable for development of indapamide sustained release solid-dosage formulation
    Antovska, Packa
    Petrusevski, Gjorgji
    Makreski, Petre
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (02) : 481 - 489
  • [6] BROMHEXINE HYDROCHLORIDE ADSORPTION BY SOME SOLID EXCIPIENTS USED IN THE FORMULATION OF TABLETS
    QTAITAT, MA
    ZUGHUL, MB
    BADWAN, AA
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (04) : 415 - 429
  • [7] Development and characterization of solid oral dosage form incorporating candesartan nanoparticles
    Nekkanti, Vijaykumar
    Pillai, Raviraj
    Venkateshwarlu, Vobalaboina
    Harisudhan, T.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2009, 14 (03) : 290 - 298
  • [8] Coprocessed Excipients for Solid Dosage Forms
    Nachaegari, Satish K.
    Bansal, Arvind K.
    Pharmaceutical Technology, 2004, 28 (01) : 52 - 64
  • [9] Formulation and development of multiparticulates dosage form of propranolol hydrochloride
    Yadav, Niti
    Lohani, Alka
    JOURNAL OF YOUNG PHARMACISTS, 2014, 6 (01) : 15 - 21
  • [10] THE USEFULNESS OF ORDERED MIXTURES IN DRUG FORMULATION OF A SOLID DOSAGE FORM
    WESTERBERG, M
    NYSTROM, C
    5TH INTERNATIONAL CONFERENCE ON PHARMACEUTICAL TECHNOLOGY, VOLS 1-5, 1989, : A278 - A287